Vai al contenuto

Interazioni tra farmaci

Enzalutamide + Erdafitinib

Gravità: Maggiore

Enzalutamide and Erdafitinib: major interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Enzalutamide is a strong CYP3A4 inducer and also induces CYP2C9. Erdafitinib is cleared by CYP2C9 and CYP3A4, so exposure may fall and its antitumor effect may be reduced.

Cosa significa questa interazione in parole semplici

Enzalutamide and Erdafitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Enzalutamide belongs to Endocrine; Erdafitinib belongs to Oncology.

Livello di evidenza: Moderate

Perché avviene

Induction of CYP3A4 and CYP2C9 by enzalutamide increases erdafitinib clearance.

Cosa fare

Avoid coadministration where possible and consider an alternative to enzalutamide. If unavoidable, monitor serum phosphate and treatment response, as erdafitinib dosing is guided by phosphate and tolerability.

Cosa chiedere al farmacista

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Enzalutamide e Erdafitinib, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Enzalutamide with Erdafitinib?

MediHelp rates the interaction as major. Enzalutamide and Erdafitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Enzalutamide is a strong CYP3A4 inducer and also induces CYP2C9. Erdafitinib is cleared by CYP2C9 and CYP3A4, so exposure may fall and its antitumor effect may be reduced.

How serious is the interaction between Enzalutamide and Erdafitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid coadministration where possible and consider an alternative to enzalutamide. If unavoidable, monitor serum phosphate and treatment response, as erdafitinib dosing is guided by phosphate and tolerability.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi